The Joint Corp. (JYNT) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $8.98. It has a SharesGrow Score of 54/100, indicating a mixed investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of JYNT = $4.07 (-54.7% from the current price, the stock appears overvalued). Analyst consensus target is JYNT = $20 (+122.7% upside).
Valuation: JYNT trades at a trailing Price-to-Earnings (P/E) of 43.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.68.
Financials: revenue is $55M, -11.5%/yr average growth. Net income is $3M, growing at -260.6%/yr. Net profit margin is 5.3% (thin). Gross margin is 76.6% (-13.8 pp trend).
Balance sheet: total debt is $2M against $15M equity (Debt-to-Equity (D/E) ratio 0.13, conservative). Current ratio is 1.59 (strong liquidity). Debt-to-assets is 3.3%. Total assets: $61M.
Analyst outlook: 5 / 8 analysts rate JYNT as buy (63%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 15/100 (Fail), Past 50/100 (Partial), Health 100/100 (Pass), Moat 35/100 (Fail), Future 73/100 (Pass), Income 45/100 (Partial).
